Element Materials Technology Acquires Nanosyn

Formosa Laboratories Acquires SynChem to Expand North American CDMO Footprint

June 3, 2024

Pharmaceuticals

Formosa Laboratories, Inc., a Taiwan-based API supplier and CDMO, has completed its acquisition of SynChem, Inc., a contract research laboratory in suburban Chicago. SynChem will operate as SynChem-Formosa with Dr. W. Paul Mar remaining as CEO as the combined operations expand Formosa's US CDMO capabilities for small-molecule APIs and ADC-related chemistries.

Novacap Acquires PCI Synthesis

June 28, 2018

Pharmaceuticals

Novacap has completed the acquisition of PCI Synthesis, a U.S.-based small-molecule CDMO with R&D and manufacturing sites in Massachusetts. The deal gives Novacap a U.S. footprint and strengthens its global pharmaceutical synthesis and commercial manufacturing capabilities.

Element Materials Technology Acquires JMI Laboratories

January 14, 2022

Healthcare Services

Element Materials Technology has acquired JMI Laboratories, a North Liberty, Iowa-based microbiology and molecular testing provider known for its SENTRY Antimicrobial Surveillance Program. The acquisition is an add-on to Element's life sciences buildout, expanding its pharmaceutical and biopharmaceutical testing capabilities across North America and Europe.

Shoei Chemical Acquires Quantum Dot Business from Nanosys

September 7, 2023

Manufacturing

Shoei Chemical, together with its North American subsidiary Shoei Electronic Materials, completed an asset purchase agreement to acquire substantially all assets of Nanosys' quantum dot business, including its sales and marketing teams, R&D team, and Silicon Valley laboratories. The deal brings Nanosys' quantum dot technology and IP under Shoei to strengthen Shoei's advanced materials and display-materials capabilities while retaining the Nanosys brand and operations in the U.S.

X-Chem Acquires IntelliSyn and AviSyn to Expand Drug Discovery Services

January 26, 2021

Biotechnology

X-Chem, a portfolio company of GHO Capital, has acquired Montreal-based IntelliSyn and its US-based sister company AviSyn to extend its drug discovery offering into medicinal chemistry, custom synthesis and scale-up process chemistry. The deal integrates downstream hit validation and lead optimisation capabilities into X-Chem’s DNA-Encoded Library (DEL) platform, enabling a streamlined screen-to-lead service for pharma and biotech clients; financial terms were not disclosed.

Element Materials Technology Acquires National Technical Systems (NTS)

September 27, 2022

Industrial Services

Element Materials Technology has completed the acquisition of National Technical Systems (NTS) from Aurora Capital Partners. The deal expands Element's North American footprint and testing, inspection and certification capabilities across aerospace, defense, automotive, medical and connected-technology end markets.